# Evaluation of Efficacy and Safety of SDN-037

> **NCT03426267** · PHASE3 · COMPLETED · sponsor: **Sun Pharma Advanced Research Company Limited** · enrollment: 325 (actual)

## Conditions studied

- Inflammation and Pain Associated With Ocular Surgery

## Interventions

- **DRUG:** SDN-037
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03426267
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-28
- **Primary completion:** 2020-03-05
- **Final completion:** 2020-03-05
- **Target enrollment:** 325 (ACTUAL)
- **Last updated:** 2021-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03426267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03426267, "Evaluation of Efficacy and Safety of SDN-037". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03426267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*